Lemonade, Inc. (NYSE:LMND – Get Free Report) insider John Sheldon Peters sold 28,985 shares of the company’s stock in a transaction that occurred on Monday, December 30th. The stock was sold at an average price of $38.67, for a total transaction of $1,120,849.95. Following the transaction, the insider now directly owns 69,508 shares of the company’s stock, valued at $2,687,874.36. This trade represents a 29.43 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
John Sheldon Peters also recently made the following trade(s):
- On Tuesday, December 3rd, John Sheldon Peters sold 1,790 shares of Lemonade stock. The stock was sold at an average price of $45.50, for a total value of $81,445.00.
Lemonade Stock Performance
Shares of NYSE:LMND traded up $1.56 during trading on Friday, reaching $37.95. The company had a trading volume of 1,819,974 shares, compared to its average volume of 1,779,737. Lemonade, Inc. has a twelve month low of $14.03 and a twelve month high of $53.85. The firm has a market capitalization of $2.71 billion, a PE ratio of -12.48 and a beta of 2.09. The firm’s fifty day moving average is $37.82 and its 200 day moving average is $24.84.
Analysts Set New Price Targets
Several analysts recently issued reports on the company. Morgan Stanley upgraded Lemonade from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $23.00 to $42.00 in a report on Wednesday, November 20th. Keefe, Bruyette & Woods downgraded Lemonade from a “market perform” rating to an “underperform” rating and boosted their price target for the company from $18.00 to $21.00 in a report on Thursday, November 7th. Jefferies Financial Group decreased their target price on Lemonade from $15.00 to $14.00 and set an “underperform” rating for the company in a research note on Wednesday, October 9th. JMP Securities boosted their target price on shares of Lemonade from $40.00 to $60.00 and gave the company a “market outperform” rating in a research note on Friday, November 22nd. Finally, BMO Capital Markets lifted their price target on Lemonade from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Thursday, November 21st. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Lemonade has an average rating of “Hold” and an average target price of $30.43.
Read Our Latest Stock Report on LMND
Institutional Investors Weigh In On Lemonade
Hedge funds and other institutional investors have recently bought and sold shares of the business. Blue Trust Inc. increased its holdings in shares of Lemonade by 220.0% in the third quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock valued at $45,000 after buying an additional 1,879 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of Lemonade by 321.3% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,462 shares of the company’s stock worth $74,000 after acquiring an additional 3,403 shares during the last quarter. Quest Partners LLC raised its position in shares of Lemonade by 1,647.6% during the third quarter. Quest Partners LLC now owns 9,105 shares of the company’s stock worth $150,000 after purchasing an additional 8,584 shares during the period. Concurrent Investment Advisors LLC purchased a new stake in shares of Lemonade during the second quarter valued at $180,000. Finally, Bristlecone Advisors LLC acquired a new position in shares of Lemonade in the 3rd quarter valued at $218,000. 80.30% of the stock is currently owned by institutional investors.
Lemonade Company Profile
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
See Also
- Five stocks we like better than Lemonade
- What Do S&P 500 Stocks Tell Investors About the Market?
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- 3 Healthcare Dividend Stocks to Buy
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- 3 Small Caps With Big Return Potential
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.